LeadIQ logo
Learn more at LeadIQ.com

Insights

Global Expansion Novo Nordisk has recently expanded its offices in Boston, Massachusetts and invested in upgrading its insulin production facility in Montes Claros, Brazil. These expansions indicate a focus on strengthening presence in key markets, opening up potential sales opportunities in these regions.

Strategic Partnerships Novo Nordisk partnered with Ascendis Pharma A/S for the development and commercialization of products utilizing the TransCon technology platform. This collaboration showcases a focus on innovation and technology, presenting opportunities for sales of cutting-edge healthcare solutions in metabolic and cardiovascular diseases worldwide.

Community Initiatives The launch of an initiative by Novo Nordisk to prevent childhood obesity in disadvantaged urban communities demonstrates a commitment to social responsibility. Engaging in community-focused initiatives not only enhances brand reputation but also opens doors for sales by addressing pressing healthcare issues.

Legal Matters Novo Nordisk's legal actions against DCA Pharmacy highlight a stance against unfair practices, ensuring compliance with regulations and quality standards. Addressing legal issues proactively can enhance trust with stakeholders and potential clients, laying a foundation for sustainable sales relationships.

Revenue Growth Potential With a revenue of over $1 billion and ongoing investments in infrastructure and technology, Novo Nordisk demonstrates financial stability and growth potential. This financial health positions the company well to invest in sales strategies, product innovation, and market expansion, presenting lucrative sales opportunities for the company.

Similar companies to Novo Nordisk

Novo Nordisk Tech Stack

Novo Nordisk uses 8 technology products and services including Facebook Pixel, SiteCatalyst, Adobe Experience Manager, and more. Explore Novo Nordisk's tech stack below.

  • Facebook Pixel
    Analytics
  • SiteCatalyst
    Analytics
  • Adobe Experience Manager
    Content Management System
  • Knockout.js
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • C#
    Programming Languages
  • Python
    Programming Languages
  • HSTS
    Security

Media & News

Novo Nordisk's Email Address Formats

Novo Nordisk uses at least 2 format(s):
Novo Nordisk Email FormatsExamplePercentage
FLast@novonordisk.comJDoe@novonordisk.com
80%
First.Last@novonordisk.comJohn.Doe@novonordisk.com
10%
FirstL@novonordisk.comJohnD@novonordisk.com
8%
LastF@novonordisk.comDoeJ@novonordisk.com
2%
First.Last@teamnovonordisk.comJohn.Doe@teamnovonordisk.com
87%
First@teamnovonordisk.comJohn@teamnovonordisk.com
6%
Last@teamnovonordisk.comDoe@teamnovonordisk.com
3%
First.Middle@teamnovonordisk.comJohn.Michael@teamnovonordisk.com
4%

Frequently Asked Questions

Where is Novo Nordisk's headquarters located?

Minus sign iconPlus sign icon
Novo Nordisk's main headquarters is located at Novo Alle Bagsværd, 2880 DK. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Novo Nordisk's phone number?

Minus sign iconPlus sign icon
You can contact Novo Nordisk's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novo Nordisk's stock symbol?

Minus sign iconPlus sign icon
Novo Nordisk is a publicly traded company; the company's stock symbol is NVO.

What is Novo Nordisk's official website and social media links?

Minus sign iconPlus sign icon
Novo Nordisk's official website is novonordisk.com and has social profiles on LinkedIn.

How much revenue does Novo Nordisk generate?

Minus sign iconPlus sign icon
As of September 2024, Novo Nordisk's annual revenue reached $5B.

What is Novo Nordisk's NAICS code?

Minus sign iconPlus sign icon
Novo Nordisk's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novo Nordisk have currently?

Minus sign iconPlus sign icon
As of September 2024, Novo Nordisk has approximately 60K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Digital & Information Officer (cdio), Senior Vice President At "global Digital, Data & It": A. R.Chief Financial Officer And Executive Vice President, Finance, Legal & Global Solutions: K. M. K.Executive Vice President, Head Of Research & Early Development (r&ed) & Chief Scientific Officer: M. S.. Explore Novo Nordisk's employee directory with LeadIQ.

What industry does Novo Nordisk belong to?

Minus sign iconPlus sign icon
Novo Nordisk operates in the Pharmaceutical Manufacturing industry.

What technology does Novo Nordisk use?

Minus sign iconPlus sign icon
Novo Nordisk's tech stack includes Facebook PixelSiteCatalystAdobe Experience ManagerKnockout.jsOpen GraphC#PythonHSTS.

What is Novo Nordisk's email format?

Minus sign iconPlus sign icon
Novo Nordisk's email format typically follows the pattern of . Find more Novo Nordisk email formats with LeadIQ.

How much funding has Novo Nordisk raised to date?

Minus sign iconPlus sign icon
As of September 2024, Novo Nordisk has raised $22M in funding. The last funding round occurred on Dec 05, 2018 for $22M.

When was Novo Nordisk founded?

Minus sign iconPlus sign icon
Novo Nordisk was founded in 1923.
Novo Nordisk

Novo Nordisk

Pharmaceutical ManufacturingBagsværd, Denmark10001+ Employees

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com.

This page isn’t intended for discussions about products.  As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. 

Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: 
https://www.novonordisk.com/contact-us/find-local-information.html

For other customer complaints, please contact us here: 
https://www.novonordisk.com/contact-us.html

Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. 

Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.

Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Section iconCompany Overview

Headquarters
Novo Alle Bagsværd, 2880 DK
Phone number
Stock Symbol
NVO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1923
Employees
10001+

Section iconFunding & Financials

  • $22M

    Novo Nordisk has raised a total of $22M of funding over 1 rounds. Their latest funding round was raised on Dec 05, 2018 in the amount of $22M.

  • $1B

    Novo Nordisk's revenue is in the range of $1B

Section iconFunding & Financials

  • $22M

    Novo Nordisk has raised a total of $22M of funding over 1 rounds. Their latest funding round was raised on Dec 05, 2018 in the amount of $22M.

  • $1B

    Novo Nordisk's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.